Our new JAMA paper has important vaccine info for immunosuppressed/transplant folks: only 17% response from 1st dose. Vaccination does not mean immunity for y'all -- please be careful out there! https://t.co/6yZh0vwNxa @CDCgov@ASTSChimera@AST_Info https://t.co/F3oonkynDs
Systematic Review of Risk factors and Incidence of Acute Kidney Injury Among Patients Treated with CAR-T cell Therapies
#AKI#CARTCellTherapy@SwethaKanduriMD
https://t.co/TWxtMSue44
‼️ pooled estimated incidence of AKI was 18.6% (95%CI 14.3-23.8%, I2 = 77%)
Low seroconversion rates after confirmed COVID infection in solid organ transplant recipients
~ only about 50 %
In @amjtransplant from @ColumbiaKidney @SumitMohanMD et al https://t.co/8WJ2Afw6iR
@GenNextMD@askrenal@NephJC My understanding is it’s from preclinical data in this trials about ADPKD.. is that correct ? .. if so where can I find Pre clinical data of these flozin studies. Thank you
Biomarkers, clinical features and rechallenge for immune checkpoint inhibitor renal immune-related adverse events
#visualabstract by @Errantnephron
https://t.co/3Z3k5Pb6HB
Membranous nephropathy - Extraordinary talk by Dr. Jha @vjha126 ✨
@GlomCon#GlomConFellowship
When to do a kidney biopsy in PLA2R positive patient? If the patient has abnormal kidney function, evidence of secondary disease or other atypical features, unless contraindicated